ABIONYX (EPA:ABNX) | WebDisclosure

Basculer en Français

8205	Companies
109399	Keywords
51579	Articles
60261	Press releases

Home
Companies
ABIONYX

BRIEF

published on 06/19/2024 at 21:20, 4 months 15 days ago

ABIONYX annonce une augmentation de capital sans droit préférentiel de souscription

Biotechnologie Actions Augmentation De Capital États-Unis Sepsis
PRESS RELEASE

published on 06/19/2024 at 21:15, 4 months 15 days ago

Inside Information / Other news releases
ABIONYX announces capital increase of c.€3.4 million with share issuance and warrants, strengthening financial position for Sepsis and US development, supported by ORSAY 53 investment company

Capital Increase Share Issuance ABIONYX Sepsis Development ORSAY 53
PRESS RELEASE

published on 06/19/2024 at 21:15, 4 months 15 days ago

Informations privilégiées / Autres communiqués
ABIONYX annonce une augmentation de capital de 3,4M€ avec suppression du DPS au profit d'une catégorie de personnes, renforçant sa trésorerie pour le développement dans le sepsis et aux États-Unis

Augmentation De Capital États-Unis Sepsis ABIONYX Suppression DPS
BRIEF

published on 06/13/2024 at 19:53, 4 months 21 days ago

ABIONYX Pharma obtient l'aval de la FDA pour une nouvelle étude sur le sepsis

FDA Étude Clinique ABIONYX Pharma Sepsis CER-001
BRIEF

published on 06/13/2024 at 19:53, 4 months 21 days ago

ABIONYX Pharma Receives FDA Approval for New Sepsis Study

FDA Clinical Study ABIONYX Pharma Sepsis CER-001
PRESS RELEASE

published on 06/13/2024 at 19:48, 4 months 21 days ago

Inside Information / Other news releases
ABIONYX Pharma completes successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial in Sepsis, marking significant progress in developing innovative therapy

FDA ABIONYX Pharma Sepsis CER-001 Pre-IND Meeting
PRESS RELEASE

published on 06/13/2024 at 19:48, 4 months 21 days ago

Informations privilégiées / Autres communiqués
ABIONYX Pharma a passé avec succès la réunion pré-IND avec la FDA pour une étude clinique de phase 2b/3 évaluant CER-001 dans le traitement de patients atteints de sepsis. La société se prépare à déposer une demande d’IND pour lancer l'étude clinique

FDA ABIONYX Pharma Sepsis CER-001 Réunion Pré-IND

Accesswire

Published on 11/04/2024 at 21:45, 7 minutes ago

Hank Payments Responds to Press Release Issued By Melrose Ventures
Published on 11/04/2024 at 21:30, 22 minutes ago

Forward Water Technologies Corp. Announces Shares for Interest Debt Settlement
Published on 11/04/2024 at 20:45, 1 hour 7 minutes ago

Koilink Technologies Inc. Appoints Transfer Online Inc. as New Transfer Agent, Enhancing Shareholder Services Amid Progress Toward Public Listing
Published on 11/04/2024 at 19:00, 2 hours 52 minutes ago

Arctic IT Government Solutions Selected as an Information Technology Support Services Contractor for the U.S. Department of the Interior, Bureau of Indian Affairs
Published on 11/04/2024 at 18:15, 3 hours 37 minutes ago

Al Salam Bank Launches ASB Capital: A New Asset Management Firm in the DIFC with AUMs of USD 4.5 Billion

View all ACCESSWIRE

EQS Group

Published on 11/04/2024 at 21:15, 36 minutes ago

EQS-Adhoc: LEG Immobilien SE: Acquisition of Brack Capital Properties N.V. through the conclusion of a share purchase agreement and a tender commitment in the event of a public offer
Published on 11/04/2024 at 19:00, 2 hours 51 minutes ago

EQS-Adhoc: Salzgitter Aktiengesellschaft: Potential voluntary public takeover bid to the shareholders of Salzgitter AG
Published on 11/04/2024 at 19:00, 2 hours 52 minutes ago

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 28 OCTOBRE 2024 au 01 NOVEMBRE 2024
Published on 11/04/2024 at 19:00, 2 hours 52 minutes ago

PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 11/04/2024 at 18:47, 3 hours 4 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 11/04/2024 at 18:13, 3 hours 38 minutes ago

Thales : lancement de l’opération 2024 d’actionnariat salarié
Published on 11/04/2024 at 18:13, 3 hours 38 minutes ago

Thales: Launch of the 2024 Employee Share Ownership Plan
Published on 11/04/2024 at 18:11, 3 hours 40 minutes ago

Monthly disclosure of the total number of shares and voting rights - 31/10/2024
Published on 11/04/2024 at 18:11, 3 hours 40 minutes ago

Déclaration mensuelle des actions et droits de vote – 31/10/2024
Published on 11/04/2024 at 17:45, 4 hours 7 minutes ago

Disclosure of trading in own shares from October 29th, 2024, to November 1st, 2024. Detailed information per transaction.

View all LES ECHOS COMFI WIRE